According to an article on PharmaTimes Online, a new report issued in Europe suggests that "European healthcare systems are failing to deliver the latest medical breakthroughs to men with advanced prostate cancer." The report, entitled “Every month matters: improving advanced prostate cancer care in Europe,” was developed either by or with funding from Astellas Pharma […]![]()
